The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Electronic Drug Delivery Systems Market Expected To Scale Between 2026 And 2030?
The electronic drug delivery systems market size has seen substantial growth in recent years. It is anticipated to expand from $11.93 billion in 2025 to $13.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The historical growth in this sector is attributable to the increasing incidence of chronic diseases, the expansion of injectable and inhalable treatments, the rising utilization of infusion-based therapies, an increase in home healthcare adoption, and the widespread presence of electronic drug delivery platforms.
The electronic drug delivery systems market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $19.44 billion, exhibiting a compound annual growth rate (CAGR) of 10.4%. This anticipated growth during the forecast period is fueled by several factors, including a heightened demand for customized drug delivery, the increasing uptake of digital health platforms, the broadening scope of remote patient monitoring, a greater emphasis on outcomes driven by treatment adherence, and the expanding incorporation of AI-powered dosing algorithms. Key developments foreseen in this period involve a surge in the adoption of intelligent drug delivery devices, a greater integration of connected and wearable delivery mechanisms, an increasing utilization of technologies for precise dose control, the proliferation of patient-focused self-administration tools, and a sharpened emphasis on tracking therapy adherence.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp
What Major Factors Are Driving The Electronic Drug Delivery Systems Market Forward?
The electronic drug delivery systems market is anticipated to grow in the future due to the increasing incidence of chronic disease. A chronic disease is characterized as a condition or illness that lasts longer than a year and requires continuous medical care. Electronic drug delivery systems are utilized to regulate drug doses and simplify their monitoring for individuals affected by chronic diseases. For example, in January 2023, the National Library of Medicine, a US-based agency, reported that the number of individuals in the US aged 50 and older with at least 1 chronic condition is expected to rise to 142.66 million by 2050. Therefore, the expanding prevalence of chronic diseases will propel the electronic delivery system market.
How Is Segmentation Applied In The Electronic Drug Delivery Systems Market Segment Analysis?
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
Which Trends Are Impacting The Progress Of The Electronic Drug Delivery Systems Market?
Leading companies in the electronic drug delivery systems market are focusing on innovative solutions, such as reusable electronic injector platforms, to improve drug administration accuracy, patient compliance, and environmental responsibility. A reusable electronic injector platform is a smart, battery-powered injection device designed for multiple uses, delivering precise medication doses while monitoring usage and supporting patient adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, introduced PRIME Nexus. This new reusable electronic injector platform aims to enhance the delivery of injectable medications, with specific improvements in precision, versatility, and sustainability for drug delivery. It is compatible with various drug container sizes, including 1 mL and 2.25 mL pre-filled syringes, and 3 mL cartridges, and can manage high-viscosity formulations up to 600 cP. The device features programmable injection control and optional connectivity for adherence tracking and sharing data with healthcare providers. Its reusable nature promotes sustainability by decreasing medical waste and reducing overall injection expenses.
Who Are The Companies Participating In The Electronic Drug Delivery Systems Market Environment?
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
Get The Full Electronic Drug Delivery Systems Market Report:
Which Region Is The Leading Market For The Electronic Drug Delivery Systems Market?
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Electronic Drug Delivery Systems Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=10734&type=smp
Browse Through More Reports Similar to the Global Electronic Drug Delivery Systems Market 2026, By The Business Research Company
Electroencephalography Eeg And Electromyography Emg Equipment Market Report 2026
Electro Medical And Electrotherapeutic Apparatus Market Report 2026
Electrocardiography Ecg Electrodes Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model